Viewing Study NCT03000660


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2026-02-20 @ 3:42 PM
Study NCT ID: NCT03000660
Status: TERMINATED
Last Update Posted: 2020-08-21
First Post: 2016-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis
Sponsor: Tufts Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None AL Amyloidosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Amyloidosis View
None AL Amyloidosis View
None Amyloid Light Chain Amylodosis View
None ABT-199 View
None Venetoclax View